DNOW IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages DNOW Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 2 Deadline in Securities Class Action First Filed by the Firm – DNOW

Rosen Law Firm reminded eligible DNOW Inc. shareholders of an October 2, 2026 deadline to seek appointment as lead plaintiff in a securities class action. The case applies to investors holding DNOW common stock as of the August 5, 2025 record date and eligible to vote at the September 9, 2025 special meeting.

Analysis

This is primarily a litigation-process catalyst rather than an operating-fundamentals signal. Plaintiff-law-firm deadline notices are routinely disseminated and, absent a disclosed damages theory, insurance exposure, discovery milestone, or a revision to transaction consideration, should not independently alter DNOW's earnings power or valuation. The near-term risk is incremental volatility and a modest event-arbitrage discount if the underlying claim challenges shareholder disclosures or a corporate transaction, not a broad deterioration in the distribution business.

The actionable issue is whether DNOW trades at a materially widening discount to any announced cash-and-stock consideration or to implied standalone value. A lead-plaintiff appointment over the next several months is not itself a merits ruling; meaningful downside would require a court denying dismissal, a settlement above D&O insurance retention, or transaction remediation. Conversely, dismissal, no competing bidder, or deal closing without revised terms would remove the litigation overhang. Consensus may overreact to the negative headline because the legal notice alone does not establish liability or quantify economic damages.

Key Decisions for Investors

• No directional position based solely on this notice; treat it as an alert pending the complaint, claimed damages, insurance disclosures, and any transaction/merger terms.
• For existing DNOW exposure, review the position before the October 2 deadline but do not de-risk solely for that date; use a court ruling, disclosed settlement reserve, or a >5% widening versus relevant deal consideration as the decision trigger.
• If DNOW is subject to announced consideration, monitor the merger-arbitrage spread versus the stated close date: a litigation-driven spread widening of 300-500 bps without an injunction, regulatory objection, or revised consideration could support a small long DNOW position, sized to binary closing risk.
• Use WCC and MRC as operating comparables for relative-value monitoring over 1-3 months; DNOW underperformance without corresponding estimate cuts or a litigation merits development would be more likely technical than fundamental.